Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Open House Medicinal Department Treaties Tofacitinib, Atc L04af01 2025-09-15
Germany Completion Of A Non-exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Iron (iii) Derisomalosis, Atc B03ac08 For The Period 01.08.2025-31.07.2027 2025-09-15
Germany Completion Of A Non -exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Safinamide, Atc N04bd03 For The Period 01.08.2025 - 31.07.2027 (plus Extension Option 1x12 Months) 2025-09-15
Germany Completion Of A Non -exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Colchicin, Atc M04ac01 For The Time 01.08.2025 - 31.07.2027 (plus Extension Option 1x12 Months) 2025-09-15
Germany Completion Of A Non-exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Nilotinib (except As A Dispatch In Apple Sauce) F. D. Z. 01.8.25 - 31.7.27 (plus Extension Option 1x12 Month) 2025-09-15
Germany Open House Pharmaceutical Dact Treaties Brinzolamid And Brimonidin, Atc S01ec24 2025-09-15
Germany Completion Of A Non -exclusive Discount Agreement According To Section 130a (8) Sgb V For The Active Ingredient Felbamat, Atc N03ax10 For The Period 01.08.2025 - 31.07.2027 2025-09-15
Germany Completion Of A Non -exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Ponesimod, Atc L04ae04 For The Period 01.08.2025 - 31.07.2027 2025-09-15
Germany Completion Of A Non -exclusive Discount Agreement According To Section 130a (8) Sgb V For The Active Ingredient Melatonin (exclusively 1mg And 5mg), Atc N05ch01 For The Period 01.08.2025 - 31.2012027 2025-09-15
Germany Open House Pharmaceutical Department Treaties Erythropoietin Zeta, Atc B03ax01 2025-09-15
Whats app